Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$16,301,742
+$2,169,242 QoQ
Shares Held
64,782
-0.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#702
of 4,153 holders
Holding Since
Dec 2021
17 quarters on record
Voting authority
Sole 61%
Shared 0%
None 39%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KENNEDY CAPITAL MANAGEMENT LLC holds $85,405,719 across 10 Drug Manufacturers - General names. ABBV ranks #2 (19.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
17,324 | $20,778,927 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
64,782 | $16,301,742 | |
| 3 | JNJ |
Johnson & Johnson
|
53,762 | $13,653,935 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
90,643 | $11,451,836 | |
| 5 | MRK |
Merck & Co., Inc.
|
74,733 | $9,603,190 | |
| 6 | AZN |
Astrazeneca PLC
|
29,684 | $5,628,680 | |
| 7 | AMGN |
Amgen Inc
|
6,130 | $2,219,795 | |
| 8 | BIIB |
Biogen Inc.
|
10,098 | $2,181,773 |
All Filings in ABBV
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,301,742 | 64,782 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $14,132,500 | 64,980 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $14,333,406 | 62,731 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $14,579,379 | 62,967 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $16,179,196 | 87,163 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $20,774,746 | 99,154 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $19,216,122 | 108,138 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $18,852,033 | 95,463 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $13,885,230 | 80,954 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $11,382,342 | 62,506 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $225,171 | 1,453 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $215,093 | 1,443 | Shares | Sole | 2023-11-14 | |
| 2023-03-31 | $214,033 | 1,343 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $215,749 | 1,335 | Shares | Sole | 2023-02-14 | |
| 2022-06-30 | $254,858 | 1,664 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $269,751 | 1,664 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $225,305 | 1,664 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||